BellRing Brands stock faces headwinds ahead of earnings, UBS maintains Neutral

Published 12/11/2025, 16:30
BellRing Brands stock faces headwinds ahead of earnings, UBS maintains Neutral

Investing.com - UBS has maintained its Neutral rating and $39.00 price target on BellRing Brands (NYSE:BRBR) ahead of the company’s fiscal fourth-quarter 2025 results scheduled for Tuesday, November 18.

The protein shake and nutritional foods maker has experienced significant stock pressure this year, with shares down approximately 63% year-to-date, according to UBS’s analysis. Recent Nielsen data showing only low-single-digit growth in October has intensified concerns about the company’s top-line performance.

While investor expectations have been lowered considerably ahead of the earnings report, UBS believes management faces challenges in providing guidance that appears both achievable and conservative without raising concerns about future growth deceleration.

UBS analysts point to similar situations with other consumer goods companies where stocks continued to face pressure despite investors believing downside was already priced in, specifically citing Simply Good Foods as an example where outlook fell below expectations.

The firm remains on the sidelines heading into the earnings announcement due to the "wide range of outcomes" possible, suggesting that evidence of an end to negative estimate revisions would be necessary before the stock can recover, despite its current valuation potentially offering a more attractive entry point after the earnings report.

In other recent news, BellRing Brands has entered into settlement agreements to resolve multiple class action lawsuits related to its Joint Juice product. The lawsuits, filed in the U.S. District Court for the Northern District of California and the Superior Court for the State of California, sought monetary damages and injunctive relief. Meanwhile, BellRing Brands has received multiple analyst ratings, reflecting varied perspectives on its stock. Bernstein SocGen Group reiterated an Outperform rating with a price target of $46.00, emphasizing the steady performance of Premier Protein sales. Bernstein also initiated coverage on the company with the same Outperform rating and price target, noting challenges in recent earnings cycles. DA Davidson maintained a Buy rating after discussions with BellRing’s leadership, though no price target was specified. Stifel also reiterated a Buy rating, highlighting a 44% increase in Premier brand consumption, aided by a Costco member savings event. These developments indicate a mix of legal resolutions and positive analyst outlooks for BellRing Brands.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.